John G. Aunins, Chief Technology Officer & EVP at Seres Therapeutics, Inc. (MCRB), sold 1,623 shares at $10.14 ($16K) on 2017-12-19, disclosed to the SEC on 2017-12-20.
Open-market sale of $16k MCRB by Chief Technology Officer & EVP. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MCRB | SELL | 2018-10-16 | $170K | — | Filing → |
| MCRB | SELL | 2018-09-19 | $655K | — | Filing → |
| MCRB | SELL | 2018-07-18 | $231K | — | Filing → |